Atlas Trials

Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor

Clinical trial NCT01326104 · COMPLETED

Trial details

NCT number
NCT01326104
Sponsor
University of Florida
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
MedulloblastomaNeuroectodermal Tumor
Start date
2010-09-07
Primary completion
2020-03-28
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.